It is time to reevaluate the management of patients with brain metastases

Neurosurgery

Volumn 75, Issue 1, 2014, Pages 1-9

  Kondziolka, Douglas ^a   Kalkanis, Steven N ^b   Mehta, Minesh P ^c   Ahluwalia, Manmeet ^d   Loeffler, Jay S ^e  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b HENRY FORD HEALTH SYSTEM   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Brain metastasis; Brain tumor; Cancer; Clinical trial; Radiosurgery; Radiotherapy; Surgery

Indexed keywords

ARTICLE; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; COGNITIVE DEFECT; HUMAN; MICROMETASTASIS; PRIMARY TUMOR; PRIORITY JOURNAL; RADIOSENSITIVITY; TREATMENT RESPONSE; WHOLE BRAIN RADIATION THERAPY; BRAIN NEOPLASMS; NEOPLASM METASTASIS; PATHOLOGY; SECONDARY;

BRAIN NEOPLASMS; HUMANS; NEOPLASM METASTASIS;

EID: 84902794629     PISSN: 0148396X     EISSN: 15244040     Source Type: Journal    
DOI: 10.1227/NEU.0000000000000354     Document Type: Article

References (49)

1. Kalkanis SN, Linskey ME. Evidence-based clinical practice parameter guidelines for the treatment of patients with metastatic brain tumors: introduction. J Neurooncol. 2010;96(1):7-10.
2. Gaspar LE, Mehta MP, Patchell RA, et al. The role of whole brain radiation therapy in the management of newly-diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol. 2010;96(1):17-32.
3. Kalkanis SN, Kondziolka D, Gaspar LE, et al. The role of surgical resection in the management of newly-diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol. 2010;96(1):33-43.
4. Linskey M, Andrews D, Asher A, et al. The role of stereotactic radiosurgery in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol. 2010;96(1):45-68.
5. Mehta MP, Paleologos NA, Mikkelsen T, et al. The role of chemotherapy in the management of newly-diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol. 2010;96(1):71-83.
6. Lin NU, Lee EQ, Aoyama H, et al. Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group. Lancet Oncol. 2013;14(10):e396-e406.
7. Lin NU, Wefel JS, Lee EQ, et al. Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group. Lancet Oncol. 2013;14(10):e407-e416.
8. Vogelbaum MA, Asher AL, Kondziolka D, et al. Modern treatment of cerebral metastases: Integrated Medical Learning (SM) at CNS 2007. J Neurooncol. 2009; 93(1):89-105.
9. Welsh JW, Komaki R, Amini A, et al. Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer. J Clin Oncol. 2013;31(7):895-902.
10. Eichler AF, Kahle KT, Wang DL, et al. EGFR mutation status and survival after diagnosis of brain metastasis in nonsmall cell lung cancer. Neuro Oncol. 2010;12 (11):1193-1199.
11. Preusser M, Berghoff AS, Schadendorf D, Lin NU, Stupp R. Brain metastasis: opportunity for drug development? Curr Opin Neurol. 2012;25(6):786-794.
12. Narayana A, Mathew M, Tam M, et al. Vemurafenib and radiation therapy in melanoma brain metastases. J Neurooncol. 2013;113(3):411-416.
13. Ma M, Qian M, Lackaye D, et al. Challenging the current paradigm of melanoma progression: brain metastasis as isolated first visceral site. Neuro Oncol. 2012;14(7): 849-858.
14. Kondziolka D, Kano H, Harrison GL, et al. Stereotactic radiosurgery as primary and salvage management for brain metastases from breast cancer. Clinical article. J Neurosurg. 2011;114(3):792-800.
15. Patchell RA, Tibbs PA, Regine W, et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA. 1998;280(17):1485-1489.
16. Patchell RA, Tibbs PA, Walsh JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med. 1990;322(8):494-500.
17. Mintz AH, Kestle J, Rathbone MP, et al. A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer. 1996;78(7):1470-1476.
18. Andrews DW, Scott CB, Sperduto PW. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomized trial. Lancet. 2004; 363(9422):1665-1672.
19. Kondziolka D, Patel A, Lunsford LD, Kassam A, Flickinger JC. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys. 1999;45(2):427-434.
20. Aoyama H, Shirato H, Tago M, et al. Stereotactic radiosurgery plus whole brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases. JAMA. 2006;295(21):2483-2491.
21. Likhacheva A, Pinnix CC, Parikh NR, et al. Predictors of survival in contemporary practice after initial radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys. 2013;85(3):656-661.
22. Bhatnagar AK, Flickinger JC, Kondziolka D, Lunsford LD. Stereotactic radio-surgery for four or more intracranial metastases. Int J Radiat Oncol Biol Phys. 2006; 64(3):898-903.
23. Baschnagel AM, Meyer KD, Chen PY, et al. Tumor volume as a predictor of survival and local control in patients with brain metastases treated with gamma knife radiosurgery. J Neurosurg. 2013;119(5):1139-1144.
24. Varlotto JM, Flickinger JC, Niranjan A, Bhatnagar A, Kondziolka D, Lunsford LD. The impact of whole brain radiation therapy on the long-term control and morbidity of patients surviving more than one year after gamma knife radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys. 2005;62(4):1125-1132.
25. Sneed PK, Lamborn KR, Forstner JM, et al. Radiosurgery for brain metastases: is whole brain radiotherapy necessary? Int J Radiat Oncol Biol Phys. 1999;43(3): 549-558.
26. Monaco EA, Faraji AH, Berkowitz O, et al. Leukoencephalopathy after whole brain radiation therapy plus radiosurgery versus radiosurgery alone for metastatic lung cancer. Cancer. 2013;119(1):226-232.
27. Li J, Bentzen SM, Renschler M, Mehta MP. Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function. J Clin Oncol. 2007;25(10):1260-1266.
28. Meyers CA, Smith JA, Bezjak A, et al. Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. J Clin Oncol. 2004;22(1):157-165.
29. Chang EL, Wefel JS, Hess KR, et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole brain irradiation: a randomized controlled trial. Lancet Oncol. 2009;10(11):1037-1044.
30. Kondziolka D, Martin JJ, Flickinger JC, et al. Long-term survivors after gamma knife radiosurgery for brain metastases. Cancer. 2005;104(12):2784-2791.
31. Mathieu D, Kondziolka D, Cooper PB, et al. Gamma knife radiosurgery in the management of malignant melanoma brain metastases. Neurosurgery. 2007;60(3): 471-481.
32. Sheehan JP, Sun MH, Kondziolka D, Flickinger J, Lunsford LD. Radiosurgery for patients with renal cell carcinoma metastatic to the brain: long-term outcomes and prognostic factors influencing survival and local tumor control. J Neurosurg. 2003; 98:342-349.
33. Sawrie SM, Guthrie BL, Spencer SA, et al. Predictors of distant brain recurrence for patients with newly diagnosed brain metastases treated with stereotactic radiosurgery alone. Int J Radiat Oncol Biol Phys. 2008;70(1):181-186.
34. Knisely JP, Yu JB, Flanigan J, Sznol M, Kluger HM, Chiang VL. Radiosurgery for melanoma brain metastases in the ipilumimab era and the possibility of longer survival. J Neurosurg. 2012;117(2):227-233.
35. Mathew M, Tam M, Ott PA, et al. Ipilumimab in melanoma with limited brain metastases treated with stereotactic radiosurgery. Melanoma Res. 2013;23(3):191-195.
36. Brown PD, Shook S, Laack NN, et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neurooncol. 2013;15(10):1429-1437.
37. Gondi V, Mehta M, Pugh S, et al. Memory preservation with conformal avoidance of the hippocampus during whole-brain radiotherapy for patients with brain metastasis: Preliminary results of RTOG 0933. Available at: https://www.astro.org/news-and-media/news-releases/2013/avoiding-specific- region-of-the-brain-during-whole-brain. aspx. ASTRO 2013, Abstract LBA1. Accessed September 23, 2013.
38. Kocher M, Soffietti R, Abacioglu U, et al. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol. 2011;29(2):134-141.
39. Tsao MN, Rades D, Wirth A, et al. Radiotherapeutic and surgical management for newly diagnosed brain metastasis: an American Society for Radiation Oncology evidence-based guideline. Pract Radiat Oncol. 2012;2(3):210-225.
40. Kondziolka D, Parry PV, Lunsford LD, et al. The accuracy of predicting survival in individual patients with cancer. J Neurosurg. 2014;120(1):24-30.
41. Auchter RM, Lamond JP, Alexander E, et al. A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis. Int J Radiat Oncol Biol Phys. 1996;35(1):27-35.
42. Rades D, Kueter JD, Veninga T, Gliemroth J, Schild SE. Whole brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole brain radiotherapy for 1-3 brain metastases: results of a matched pair analysis. Eur J Cancer. 2009;45(3):400-404.
43. Rutigliano MJ, Lunsford LD, Kondziolka D, Strauss MJ, Khanna V, Green M. The cost effectiveness of stereotactic radiosurgery versus surgical resection in the treatment of solitary metastatic brain tumors. Neurosurgery. 1995;37(3):445-453.
44. Mehta M, Noyes W, Craig B, et al. A cost-effectiveness and cost-utility analysis of radiosurgery vs. resection for single brain metastasis. Int J Radiat Oncol Biol Phys. 1997;39(2):445-454.
45. Lee WY, Cho DY, Lee HC, et al. Outcomes and cost-effectiveness of gamma knife radiosurgery and whole brain radiotherapy for multiple metastatic brain tumors. J Clin Neurosci. 2009;16(5):630-634.
46. Suh JH, Stea B, Nabid A, et al. Phase III study of efaproxiral as an adjunct to whole-brain radiation therapy for brain metastases. J Clin Oncol. 2006;24(1):106-114.
47. Murray KJ, Scott C, Greenberg HM, et al. A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104. Int J Radiat Oncol Biol Phys. 1997;39(3):571-574.
48. Komarnicky LT, Phillips TL, Martz K, Asbell S, Isaacson S, Urtasun R. A randomized phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916). Int J Radiat Oncol Biol Phys. 1991;20(1):53-58.
49. Anders CK, Deal AM, Miller CR, et al. The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases. Cancer. 2011;117(8):1602-1611.